scholarly journals Formation of Systemic Changes Features with Fatal Complications of Metabolic Syndrome and Chronic Diffuse Liver Diseases

Author(s):  
Boris Fishman ◽  
Vladimir Kulikov ◽  
Svetlana Butrimova ◽  
Spartak Turmakhanov ◽  
Mikhail Yukhno ◽  
...  

2010 ◽  
Vol 28 (1) ◽  
pp. 192-196 ◽  
Author(s):  
Marie-Luise Berres ◽  
Andreas Nellen ◽  
Hermann E. Wasmuth


2013 ◽  
Vol 3 (3) ◽  
pp. 18-30
Author(s):  
M. Abrahamovych ◽  
◽  
O. Abrahamovych ◽  
O. Fayura ◽  
◽  
...  




ICANN ’93 ◽  
1993 ◽  
pp. 948-948
Author(s):  
J. M. Thijssen ◽  
H. J. Huisman ◽  
M. S. klein Gebbink ◽  
J. T. M. Verhoeven ◽  
T. E. Schouten


2021 ◽  
Vol 11 ◽  
pp. 151-163
Author(s):  
Adebowale Emmanuel Aladejana ◽  
Elizabeth Bosede Aladejana

Metabolic syndrome (MS) is a metabolic condition commonly associated with central adiposity and altered liver function parameters (LFPs). Several studies have suggested these altered LFPs as a result of fatty liver diseases (e.g., non-alcoholic fatty liver diseases) often prevalent in MS. Since altered LFPs are very common in MS, there is a possibility they can be used as predictors of MS. However, only a few studies have been carried out to evaluate this possibility. This study, therefore, aimed to evaluate the potential of LFPs as predictors or risk factors of MS. The study groups included 50 individuals diagnosed with MS (case group) and 50 apparently normal individuals (control) from Ibadan, Oyo State, Nigeria. Anthropometric measurements, phlebotomy, liver function tests, and lipid profile estimations were done using standard procedures. (The result and conclusion section has been omitted).



2007 ◽  
Vol 61 (1) ◽  
pp. 1-2 ◽  
Author(s):  
Okan Akhan


Pharmateca ◽  
2019 ◽  
Vol 2_2019 ◽  
pp. 42-47
Author(s):  
E.A. Mezikova Mezikova ◽  
V.D. Zavadovskaya Zavadovskaya ◽  
E.V. Beloborodova Beloborodova ◽  
I.V. Dolgalev Dolgalev ◽  
O.S. Tonkikh Tonkikh ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document